IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
March 10 2025 - 7:30AM
IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today
announced that it will participate in the
37th Annual Roth
Conference.
Iradimed’s CFO, Jack Glenn, and CCO, Jeff Chiprin, will host
one-on-one meetings between company management and investors at the
37th Annual Roth Conference, which will be held at the Laguna
Cliffs Marriott in Dana Point, CA, on March 17 and 18, 2025.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in developing innovative
Magnetic Resonance Imaging (“MRI”) compatible medical devices. We
design, manufacture, market, and distribute MRI-compatible medical
devices, accessories, disposables, and related services.
We are the only provider of a non-magnetic intravenous (“IV”)
infusion pump system designed to be safe during MRI procedures. We
were the first to develop an infusion delivery system that
eliminated many dangers and problems during MRI procedures.
Standard infusion pumps contain magnetic and electronic components
that can create radio frequency interference and are dangerous to
operate in the presence of the powerful magnet that drives an MRI
system. Our patented MRidium® MRI-compatible IV infusion pump
system has a non-magnetic ultrasonic motor, uniquely designed
non-ferrous parts, and other unique features to deliver anesthesia
safely and predictably, and other IV fluids during various MRI
procedures. Our pump solution provides a seamless approach that
enables accurate, safe, and dependable fluid delivery before,
during, and after an MRI scan, which is essential to critically ill
patients who cannot be removed from their vital medications and
children and infants who must generally be sedated to remain
immobile during an MRI scan.
Our 3880 MRI-compatible patient vital signs monitoring system
has been designed with non-magnetic components and other unique
features to monitor a patient’s vital signs safely and accurately
during various MRI procedures. The IRADIMED 3880 system operates
dependably in magnetic fields up to 30,000 gauss, which means it
can operate virtually anywhere in the MRI scanner room. The
IRADIMED 3880 has a compact, lightweight design, allowing it to
travel with the patient from the critical care unit to the MRI and
back, resulting in increased patient safety through uninterrupted
vital signs monitoring and decreasing the amount of time critically
ill patients are away from critical care units. The features of the
IRADIMED 3880 include wireless ECG with dynamic gradient filtering;
wireless SpO2 using Masimo® algorithms; non-magnetic respiratory
CO2; invasive and non-invasive blood pressure; patient temperature,
and optional advanced multi-gas anesthetic agent unit featuring
continuous Minimum Alveolar Concentration measurements. The
IRADIMED 3880 MRI-compatible patient vital signs monitoring system
has an easy-to-use design and effectively communicates patient
vital signs information to clinicians.
For more information, please visit www.iradimed.com.
Media Contact:John Glenn Chief Financial OfficerIRADIMED
CORPORATION(407) 677-8022InvestorRelations@iradimed.com
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Mar 2025 to Apr 2025
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Apr 2024 to Apr 2025
